Medicina
Departamento
Saarland University
Sarrebruck, AlemaniaPublicaciones en colaboración con investigadores/as de Saarland University (13)
2024
-
Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023
Transplant Infectious Disease, Vol. 26, Núm. 1
2022
-
Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021
Transplant Infectious Disease, Vol. 24, Núm. 6
-
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation
The oncologist, Vol. 27, Núm. 7, pp. e561-e570
2019
-
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
Critical Reviews in Oncology/Hematology, Vol. 134, pp. 39-45
2017
-
Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis
American Heart Journal, Vol. 193, pp. 46-54
2016
-
Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: Results from the randomized routine early invasive clinical trials
Cardiovascular Revascularization Medicine, Vol. 17, Núm. 5, pp. 295-301
2015
-
Adjuvant bisphosphonate treatment in early breast cancer: Meta-analyses of individual patient data from randomised trials
The Lancet, Vol. 386, Núm. 10001, pp. 1353-1361
-
Consistency of benefit from an early invasive strategy after fibrinolysis: A patient-level meta-analysis
Heart, Vol. 101, Núm. 19, pp. 1554-1561
2014
-
A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel/prednisone in patients with castration-resistant prostate cancer
European Urology, Vol. 65, Núm. 3, pp. 516-520
-
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: A pooled analysis of individual patient data
The Lancet Oncology, Vol. 15, Núm. 4, pp. 406-414
-
Routine invasive management early after fibrinolysis: Relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials
American Heart Journal, Vol. 168, Núm. 5, pp. 757-765.e3
2010
-
Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: A meta-analysis
European Heart Journal, Vol. 31, Núm. 17, pp. 2156-2169